Indaptus Therapeutics Inc

INDP

—

Build a strategy around INDP

Indaptus Therapeutics Inc AI Insights

Informational only. Not investment advice.

As of 2026-03-12

No AI insights available.

Professional, Scientific, and Technical Services → Professional, Scientific, and Technical Services

Metric	Value	YoY Growth	Industry Percentile
Market Cap	$441.65M		—
Enterprise Value	$440.15M		—
P/E Ratio	0.00		—
Total Revenue - TTM	$0		—
Earnings Per Share (diluted) - TTM	$-12.70		—
Operating Margin - TTM	0%		—
Net Margin - TTM	0%		—
Free Cash Flow - TTM	$-16.79M		—
Return on Common Equity - TTM	-932%	-672.8%	—
Beta 5Y (Monthly)	unknown		—

No dividends

1 stock split

06/27/2528:1 split

Filing Date	Report Date	Report Type	Filing Link
05/15/26	03/31/26	10-Q	0001493152-26-023362
03/17/26	12/31/25	10-K	0001493152-26-010585
11/12/25	09/30/25	10-Q	0001493152-25-021759
08/13/25	06/30/25	10-Q	0001641172-25-023333
05/14/25	03/31/25	10-Q	0001641172-25-010099
03/13/25	12/31/24	10-K	0001493152-25-010136
11/12/24	09/30/24	10-Q	0001493152-24-044537
08/12/24	06/30/24	10-Q	0001493152-24-031158
05/08/24	03/31/24	10-Q	0001493152-24-018162
03/13/24	12/31/23	10-K	0001493152-24-009769
11/06/23	09/30/23	10-Q	0001493152-23-039523
08/14/23	06/30/23	10-Q	0001493152-23-028059
05/11/23	03/31/23	10-Q	0001493152-23-016268
03/17/23	12/31/22	10-K	0001493152-23-008010
11/10/22	09/30/22	10-Q	0001493152-22-031392
08/08/22	06/30/22	10-Q	0001493152-22-021562
05/12/22	03/31/22	10-Q	0001493152-22-012931
03/21/22	12/31/21	10-K	0001493152-22-007319
11/15/21	09/30/21	10-Q	0001493152-21-028318
08/16/21	06/30/21	10-Q	0001493152-21-020172
05/12/22	03/31/21	10-Q	0001493152-22-012931
03/21/22	12/31/20	10-K	0001493152-22-007319
11/15/21	09/30/20	10-Q	0001493152-21-028318
08/16/21	06/30/20	10-Q	0001493152-21-020172